X-154405446-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001303620.2(DNASE1L1):c.123C>A(p.Asp41Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,192,507 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001303620.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000353 AC: 4AN: 113178Hom.: 0 Cov.: 24 AF XY: 0.0000283 AC XY: 1AN XY: 35312
GnomAD3 exomes AF: 0.0000176 AC: 3AN: 170150Hom.: 0 AF XY: 0.0000355 AC XY: 2AN XY: 56406
GnomAD4 exome AF: 0.00000834 AC: 9AN: 1079329Hom.: 0 Cov.: 31 AF XY: 0.00000859 AC XY: 3AN XY: 349377
GnomAD4 genome AF: 0.0000353 AC: 4AN: 113178Hom.: 0 Cov.: 24 AF XY: 0.0000283 AC XY: 1AN XY: 35312
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.123C>A (p.D41E) alteration is located in exon 2 (coding exon 1) of the DNASE1L1 gene. This alteration results from a C to A substitution at nucleotide position 123, causing the aspartic acid (D) at amino acid position 41 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at